Open full COA (PDF)Tirzepatide
Dual GIP/GLP-1 receptor agonist studied in metabolic, glucose-regulation and body-composition research.
| Purity (HPLC) | ≥ 99.0% |
|---|---|
| Available sizes | 10 mg, 15 mg, 30 mg, 60 mg |
| Physical form | Lyophilized powder |
| Storage | -20°C, desiccated, protected from light |
What is Tirzepatide?
Tirzepatide is a dual-agonist research peptide that engages both the GIP and GLP-1 receptors in a single molecule. Combining the two incretin pathways is the defining feature of the compound and the reason it is studied separately from single-pathway GLP-1 analogs.
It is supplied as a lyophilized powder and reconstituted before laboratory use — see the reconstitution guide and calculator.
Research context
GIP and GLP-1 are the two principal incretin hormones involved in glucose regulation and energy balance. Research models examine how engaging both simultaneously differs from engaging either alone, particularly across glucose-handling and body-composition endpoints.
For the next step up in receptor coverage, Retatrutide adds glucagon-receptor activity to the same pair; our Retatrutide vs. Tirzepatide comparison covers the difference. Cagrilintide, an amylin analog, is studied on a different pathway again. Broader background is in the overview of metabolic research peptides.
Purity and third-party testing
Every batch is independently analysed by Testides and Peptide Test Canada and ships with a certificate of analysis reporting HPLC purity and mass-spectrometry identity. See how to read a certificate of analysis, peptide purity explained, and our Research and Quality page.
Handling and storage
Keep the lyophilized vial cold and out of direct light; reconstituted material is refrigerated and has a shorter shelf life. Details are in the storage guide, and bacteriostatic vs. sterile water covers diluent choice.
Related research compounds
Tirzepatide is part of our metabolic and weight research collection, alongside Retatrutide, Cagrilintide and Tesamorelin. For orientation, see Peptides 101 or the knowledge hub.
Research Use Only. Supplied strictly for in-vitro laboratory research and development. Not for human or animal consumption, diagnostic, or therapeutic use.
Frequently asked
No. Tirzepatide is supplied strictly as a reference material for in-vitro laboratory research. It is not for human or animal consumption and is not intended for diagnostic or therapeutic use.
Yes. Every batch is independently tested by Testides and Peptide Test Canada for HPLC purity and mass-spectrometry identity, and ships with a batch-specific certificate of analysis (COA).
Tirzepatide is available in 10 mg, 15 mg, 30 mg, 60 mg. Per-vial pricing is shown on this page.
Tirzepatide is supplied as lyophilized powder. Use the reconstitution calculator to work out concentration and dosing volumes for your research, and see the storage and handling guide for temperature and shelf-life guidance. Store the lyophilized vial at -20 degrees C, desiccated and protected from light.
What researchers say
No reviews yet
Be the first to review Tirzepatide. A review left from the email address on an order is labelled as a verified purchase.
Write a review
Please review the material itself — purity, packaging, shipping and handling. We cannot publish reviews describing human or animal use, dosing, or health outcomes, because everything we supply is strictly for in-vitro laboratory research. Every review is read before it appears.
